SPP1, which is highly expressed in non-small cell lung cancer, breast cancer and colorectal cancer, evades tumor immunization by regulating the polarization of macrophages in tumor microenvironment, recruiting and inhibiting the activation of T cells, and is related to the prognosis of patients and resistance of drugs [56–62]. This evidence concerns the gene SPP1 and colorectal cancer.